NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Parabolic Drugs Limited (NSE: PARABDRUGS)

 
PARABDRUGS Technical Analysis
1
As on N/A PARABDRUGS SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PARABDRUGSSHARE Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A | 52 Week Low N/A
 
NSE INDIA Most Active Stocks
IDEA 8.50 -5.56%
SUZLON 8.45 4.32%
PNB 34.90 0.14%
ZOMATO 61.20 5.43%
BEL 99.00 -0.15%
TATASTEEL 96.85 1.73%
JPPOWER 7.10 -2.07%
DISHTV 18.00 9.42%
YESBANK 15.50 0.32%
EXCEL 0.65 0.00%
 
NSE INDIA Top Gainers Stocks
PRICOLLTD 193.00 18.40%
APOLSINHOT 1167.90 18.31%
SPARC 231.10 14.86%
IVC 9.00 13.21%
IVC 9.00 13.21%
IVC 9.00 13.21%
APOLLO 179.05 12.89%
MARINE 33.10 11.82%
OSWALAGRO 42.10 11.08%
RML 396.60 10.97%
 
NSE INDIA Top Losers Stocks
SVPGLOB 30.70 -12.16%
CMICABLES 18.10 -9.27%
SILLYMONKS 28.00 -8.05%
BASML 49.30 -7.59%
ANSALHSG 5.80 -6.45%
AARTIIND 733.85 -6.06%
VALIANTORG 722.25 -5.72%
AGI 315.25 -5.57%
AGI 315.25 -5.57%
AGI 315.25 -5.57%
 
 
PARABDRUGS
Daily Charts
PARABDRUGS
Intraday Charts
Whats New @
Bazaartrend
PARABDRUGS
Free Analysis
 
PARABDRUGS Important Levels Intraday
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
 
PARABDRUGS Target September 2022
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
PARABDRUGS Weekly Target
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
PARABDRUGS Target2022
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
Parabolic Drugs Limited ( NSE INDIA Symbol : PARABDRUGS )
Sector : Pharmaceuticals And Other Stocks in Same Sector
 
PARABDRUGS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 46.29 Sideways
MFI (14) MFI is 25.84 Sideways
CCI (20) CCI is 71.68 Sideways
WILLIAM %R (14) William %R is Above -20 Over Bought
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 1.14
10 Day Avg Volume Traded -58.58 % Less then 10 Day Average Volume
 
PARABDRUGS Other Details
Segment BE
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website >
 
PARABDRUGS Address
PARABDRUGS
N/A
 
PARABDRUGS Latest News
 
Your Comments and Response on Parabolic Drugs Limited
 
PARABDRUGS Business Profile
Parabolic Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 27.17 crore.The company has reported a standalone sales of Rs 117.12 crore and a Net Loss of Rs 22.32 crore for the quarter ended Sep 2013.The company management includes Pranav Gupta - Chairman & Managing Director, Vineet Gupta - Whole Time Director, Balbir Singh Bhasin - Director, Arun Mathur - Director, Nikhil Goel - Director, Balwan Bansal - Director. It is listed on the BSE with a BSE Code of 533211 and the NSE with an NSE Code of PARABDRUGS.Its Registered office is at S.C.O 99-100, Top Floor,,Sector 17 - B Chandigarh,Chandigarh - 160017.Their Registrars are Link Intime India Pvt. Ltd.
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service